p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart
Tomohiro Yokota,Jin Li,Jijun Huang,Zhaojun Xiong,Qing Zhang,Tracey Chan,Yichen Ding,Christoph Rau,Kevin Sung,Shuxun Ren,Rajan Kulkarni,Tzung Hsiai,Xinshu Xiao,Marlin Touma,Susumu Minamisawa,Yibin Wang
DOI: https://doi.org/10.1172/jci135859
IF: 19.456
2020-08-31
Journal of Clinical Investigation
Abstract:In the mammalian heart, the left ventricle (LV) rapidly becomes more dominant in size and function over the right ventricle (RV) after birth. The molecular regulators responsible for this chamber-specific differential growth are largely unknown. We found that cardiomyocytes in the neonatal mouse RV had lower proliferation, more apoptosis, and a smaller average size compared with the LV. This chamber-specific growth pattern was associated with a selective activation of p38 mitogen-activated protein kinase (MAPK) activity in the RV and simultaneous inactivation in the LV. Cardiomyocyte-specific deletion of both the <i>Mapk14</i> and <i>Mapk11</i> genes in mice resulted in loss of p38 MAPK expression and activity in the neonatal heart. Inactivation of p38 activity led to a marked increase in cardiomyocyte proliferation and hypertrophy but diminished cardiomyocyte apoptosis, specifically in the RV. Consequently, the p38-inactivated hearts showed RV-specific enlargement postnatally, progressing to pulmonary hypertension and right heart failure at the adult stage. Chamber-specific p38 activity was associated with differential expression of dual-specific phosphatases (DUSPs) in neonatal hearts, including DUSP26. Unbiased transcriptome analysis revealed that IRE1α/XBP1–mediated gene regulation contributed to p38 MAPK–dependent regulation of neonatal cardiomyocyte proliferation and binucleation. These findings establish an obligatory role of DUSP/p38/IRE1α signaling in cardiomyocytes for chamber-specific growth in the postnatal heart.
medicine, research & experimental